Shedding of TNF receptors in multiple sclerosis patients

Neurology

Volumn 53, Issue 7, 1999, Pages 1409-1414

  Jurewicz, Anna M ^a   Walczak, Agata K ^a   Selmaj, Krzysztof W ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

MS; Peripheral blood mononuclear cells; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; DEMYELINATION; DRUG RECEPTOR BINDING; FEMALE; GENE DISRUPTION; HUMAN; MALE; MEMBRANE BINDING; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS SHEDDING;

EID: 0032692878     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.7.1409     Document Type: Article

References (35)

1. Chung IY, Benveniste EN. Tumor necrosis factor-alpha production by astrocytes: induction by lipopolysaccharide, INF-gamma and IL-beta. J Immunol 1990;144:2999-3007.
2. Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function and mechanism of action. Am J Physiol 1992;263:C1-C16.
3. Selmaj KW, Farooq M, Norton WT, Raine CS, Brosnan CF. Proliferation of astrocytes in vitro in response to cytokines: a primary role for tumor necrosis factor. J Immunol 1990;144: 129-135.
4. Robbins DS, Shirazi Y, Drysdale B-E, et al. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol 1987;139:2593-2597.
5. Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocytes damage in vitro. Ann Neurol 1988;23: 339-345.
6. Butt AM, Jenkins HG. Morphological changes in oligodendrocytes in the intact mouse optic nerve following intravitreal injection of tumor necrosis factor. J Neuroimmunol 1994;51: 27-33.
7. Hoffman FM, Hinton DR, Johnson K, Merrill JE. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989;170:607-612.
8. Selmaj KS, Raine CS, Canella B, Brosnan CF. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 1991;87:949-954.
9. Sharief MK, Hentges R. Association between tumor necrosis factor alpha and disease progression in patients with multiple sclerosis. N Eng J Med 1991;325:467-472.
10. Rieckmann P, Albrecht M, Kitze B, et al. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology 1994;44:1523-1526.
11. Spuler S, Yousry T, Scheller A, et al. Multiple sclerosis: prospective analysis of TNF-alpha and 55 kDA TNF receptor in CSF and serum in correlation with clinical and MRI activity. J Neuroimmunol 1996;66:57-64.
12. Ruddle NH, Bergman CM, McGrath KM, et al. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 1990;172: 1193-1200.
13. Selmaj K, Raine CS, Cross AH. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 1991;30:694-700.
14. Hohmann H, Remy R, Brockhaus M, vaan Loon APGM. Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). J Biol Chem 1989;264: 14927-14934.
15. Frei K, Eugeter H-P, Bobst M, Constantinescu CS, Levi E, Fontana A. Tumor necrosis factor a and lymphotoxin a are not required for induction of acute experimental autoimmune encephalomyelitis. J Exp Med 1997;12:2177-2182.
16. Suen WE, Bergman CM, Hjelmstrom P, Ruddle NH. A critical role for lymphotoxin in experimental allergic encephalomyelitis. J Exp Med 1997;186:1233-1240.
17. Brockhaus M, Schoenfeld HJ, Schlager EJ, Hunziker W, Lesslauer W, Loetscher HR. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. PNAS 1990;87:3127-3131.
18. Beutler B, van Huffel C. Unraveling function in the TNF ligand and receptors families. Science 1994;264:667-668.
19. Loetscher H, Steinmetz M, Lesslauer W. Tumor necrosis factor: receptors and inhibitors. Cancer Cells 1991;3:221-226.
20. Aderka D, Engelmann H, Maor Y, Brakebusch, Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992;175:323-329.
21. Black RA, Rauch CT, Kozlovsky CJ. A metalloproteinase disintegrin that releases TNF-alpha from cells. Nature 1997;385: 729-733.
22. Moss ML, Jin SL, Becher JD: Cloning of a disintegrin metalloproteinase that process precursor TNF-alpha. Nature 1997; 385:733-736.
23. Tsukada N, Matsuda M, Miyagi K, Yanagasiwa N. Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebro-spinal fluid of patients with multiple sclerosis. Neurology 1993;43:2679-2682.
24. Tsukada N, Matsuda M, Miyagi K, Yanagasiwa N. Increased levels of soluble tumor necrosis factor receptor in patients with multiple sclerosis and HTLV-1 associated myelopathy. J Neuroimmunol 1994;52:33-40.
25. Poser CM. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
26. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;1444-1452.
27. Pinckard JK, Sheehan KCF, Arthur CD, Schreiber RD. Constitutive shedding of both p55 and p75 murine TNF receptors in vivo. J Immunol 1997;158:3869-3873.
28. Higuchi M, Aggarwal BB. TNF induces internalization of the p60 receptor and shedding of p80 receptor. J Immunol 1994; 152:3550-3558.
29. Bemelmans MH, Abramowicz D, Gouma DJ, Goldman M, Buurman WA. In vitro T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice: effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-INF-gamma antibodies. J Immunol 1994;153:499-506.
30. Glabinski A, Mirecka M, Pokoca L. Tumor necrosis factor alpha but not lymphotoxin is overproduced by blood mononuclear cells in multiple sclerosis. Acta Neurol Scand 1995;91: 276-279
31. Benvenuto R, Paroli M, Butinelli C et al. Tumor necrosis factor alpha synthesis by cerebrospinal fluid derived T cell clones from patients with multiple sclerosis. Clin Exp Immunol 1991;84:97-102.
32. Powel MB, Mitchel D, Lederman J, et al. Lymphotoxin and tumor necrosis factor production by myelin basic protein specific T cell clones correlates with encephalitogenocity. Int Immunol 1990;2:538-544
33. Douni E. and G. Kollias. A critical role of the p75 tumor necrosis factor receptor (p75 TNF-R) in organ inflammation independent of TNF, lymphotoxin a, or the p55TNF-R. J Exp Med 1998,188:1343-1352
34. Crowe PD, VanArsdale TL, Goodwin RG, Ware CF. Specific induction of 80-kDa tumor necrosis factor receptor shedding in T lymphocytes involves the cytoplasmic domain and phosphorylation. J Immunol 1993;151:6882-6890
35. Merrill JE, Strom SR, Ellison GW, Myers LW. In vitro study of mediators of inflammation in multiple sclerosis. J Clin Immunol 1989;9:84-96.